Creative Medical Technology Holdings, Inc. (NASDAQ:CELZ – Get Free Report)’s share price crossed below its fifty day moving average during trading on Friday . The stock has a fifty day moving average of $2.40 and traded as low as $2.18. Creative Medical Technology shares last traded at $2.27, with a volume of 8,355 shares.
Creative Medical Technology Trading Up 4.1 %
The business has a fifty day moving average of $2.40 and a 200-day moving average of $3.12. The company has a market cap of $3.97 million, a PE ratio of -0.60 and a beta of 1.78.
Creative Medical Technology Company Profile
Creative Medical Technology Holdings, Inc, a commercial stage biotechnology company, focuses on novel biological therapeutics in the fields of immunotherapy, endocrinology, urology, neurology, and orthopedics in the United States. The company offers CaverStem to treat erectile dysfunction; FemCelz for the treatment of loss of genital sensitivity and dryness; and StemSpine, a regenerative stem cell procedure to treat degenerative disc disease.
Featured Articles
- Five stocks we like better than Creative Medical Technology
- The Most Important Warren Buffett Stock for Investors: His Own
- Top ETFs That Beat the Market in 2024 and Could Do It Again
- Insider Buying Explained: What Investors Need to Know
- J.B. Hunt Leads Truckers Lower: Buy Them While They’re Down?
- ESG Stocks, What Investors Should Know
- MarketBeat Week in Review – 01/13 – 01/17
Receive News & Ratings for Creative Medical Technology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Creative Medical Technology and related companies with MarketBeat.com's FREE daily email newsletter.
